Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 272,723 | 293,141 | 272,564 | 356,909 | 286,149 |
| Operating Income | -272,723 | -293,141 | -272,564 | -356,909 | -286,149 |
| Other Income | 5,964 | 9,886 | 3,088 | 981 | 844 |
| Pre-tax Income | -266,759 | -283,255 | -269,476 | -355,928 | -285,305 |
| Net Income Continuous | -266,759 | -283,255 | -269,476 | -355,928 | -285,305 |
| Net Income | $-266,759 | $-283,255 | $-269,476 | $-355,928 | $-285,305 |
| EPS Basic Total Ops | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 |
| EPS Basic Continuous Ops | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 |
| EPS Diluted Total Ops | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 |
| EPS Diluted Continuous Ops | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -1.63 | -1.81 | -1.79 | -11.56 |
| EBITDA(a) | $-255,332 | $-268,584 | $-256,939 | $-345,839 | $-280,228 |